1. Home
  2. WNEB vs CBUS Comparison

WNEB vs CBUS Comparison

Compare WNEB & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western New England Bancorp Inc.

WNEB

Western New England Bancorp Inc.

N/A

Current Price

$13.15

Market Cap

259.2M

Sector

Finance

ML Signal

N/A

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$1.63

Market Cap

69.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNEB
CBUS
Founded
1853
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Agricultural Chemicals
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
259.2M
69.9M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
WNEB
CBUS
Price
$13.15
$1.63
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$11.00
$20.00
AVG Volume (30 Days)
48.8K
169.0K
Earning Date
01-27-2026
11-13-2025
Dividend Yield
2.13%
N/A
EPS Growth
27.15
N/A
EPS
0.66
N/A
Revenue
$79,080,000.00
$3,794,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.48
$109.96
P/E Ratio
$20.01
N/A
Revenue Growth
9.08
N/A
52 Week Low
$7.63
$1.09
52 Week High
$13.45
$4.24

Technical Indicators

Market Signals
Indicator
WNEB
CBUS
Relative Strength Index (RSI) 75.41 57.01
Support Level $12.62 $1.50
Resistance Level $13.45 $1.75
Average True Range (ATR) 0.35 0.14
MACD 0.08 0.04
Stochastic Oscillator 82.99 69.23

Price Performance

Historical Comparison
WNEB
CBUS

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: